gip/glp-1 agonists The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review Upcoming wave of hormone-based therapies
Description
Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.
Physicians on Sermo share experiences with GLP-1 weight loss drugs and risks
Is microdosing semaglutide or tirzepatide safe
Start with 1-2 capsules per day for 3-5 days to assess comfort, then increase to 3 capsules per day
Participation in this program does not replace healthy lifestyle habits, including balanced nutrition and regular movement
